Potential of a novel polyherbal formulation BASANT for prevention of Chlamydia trachomatis infection

International Journal of Antimicrobial Agents

Volumn 32, Issue 1, 2008, Pages 84-88

  Bhengraj, A R ^a   Dar, Sajad A ^b   Talwar, G P ^b   Mittal, A ^a  

^a SAFDARJUNG HOSPITAL CAMPUS   (India)

^b Talwar Research Foundation   (India)

Author keywords

Chlamydia trachomatis; Herbal; MIC; Prevention; Susceptibility

Indexed keywords

ALOE VERA EXTRACT; BASANT; CURCUMIN; DOXYCYCLINE; EMBLICA OFFICINALIS EXTRACT; HERBACEOUS AGENT; SAPONIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG INHIBITION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; CHLAMYDIA TRACHOMATIS; COLONY COUNT, MICROBIAL; EPITHELIAL CELLS; FEMALE; HELA CELLS; HUMANS; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; PLANTS, MEDICINAL; TIME FACTORS;

EID: 46249093485     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.02.010     Document Type: Article

References (14)

1. Morre S.A., Rozendaal L., van Valkengoed I.G.M., Boeke A.J.P., van Voorst Vader P.C., Schirm J., et al. Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?. J Clin Microbiol 38 (2000) 2292-2296
2. Abdelrahman Y.M., and Belland R.J. The chlamydial developmental cycle. FEMS Microbiol Rev 29 (2005) 949-959
3. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 55 (2006) 1-100
4. Horner P. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection. Sex Transm Infect 82 (2006) 340-343
5. Davis R.H., Leitner M.G., Russo J.M., and Byrne M.E. Wound healing. Oral and topical activity of Aloe vera. J Am Podiatr Med Assoc 79 (1989) 559-562
6. Levine M. New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med 314 (1986) 892-902
7. Chandra D., and Gupta S.S. Anti-inflammatory and anti-arthritic activity of volatile oil of Curcuma longa (Haldi). Indian J Med Res 60 (1972) 138-142
8. Jing Z., Yong Z., Yan Z., and Wei C. Anti-tumor effect of curcumin on human cervical carcinoma HeLa cells in vitro and in vivo. Chin J Cancer Res 19 (2007) 32-36
9. Suchland R.J., Geisler W.M., and Stamm W.E. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp. Antimicrob Agents Chemother 47 (2003) 636-642
10. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
11. Cross N.A., Kellock D.J., Kinghorn G.R., Taraktchoglou M., Bataki E., Oxley K.M., et al. Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method. Antimicrob Agents Chemother 43 (1999) 2311-2313
12. Cles L.D., Bruch K., and Stamm W.E. Staining characteristics of six commercially available monoclonal immunofluorescence reagents for direct diagnosis of Chlamydia trachomatis infections. J Clin Microbiol 26 (1988) 1735-1737
13. Mpiga P., and Ravaoarinoro M. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937). Int J Antimicrob Agents 4 (2006) 316-324
14. Wang S.A., Papp J.R., Stamm W.E., Peeling R.W., Martin D.H., and Holmes K.K. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis 191 (2005) 917-923